本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Viridian Therapeutics, Inc.

15.67
+0.44002.89%
盘后15.670.00000.00%16:20 EDT
成交量:39.64万
成交额:622.15万
市值:12.79亿
市盈率:-4.70
高:15.94
开:15.17
低:14.98
收:15.23
数据加载中...
2021/05/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/06

重要事件披露

8-K - Current report
2021/04/26

重要事件披露

8-K - Current report
2021/03/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/03/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/20

重要事件披露

8-K - Current report
2021/01/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/05

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/01/04

重要事件披露

8-K - Current report
2020/12/21

SEC问询函

CORRESP [Cover] - Correspondence